Julie R

Biography

Ms. Rezler has been appointed to the role of Vice President, Corporate Development since October 2015. Ms. Rezler brings to Pacgen over 15 years of international public company experience in the life sciences sector, including countries such as the U.S., Canada, Asia, Europe and Africa. She brings a track record in corporate development and strategy, specializing in customer needs assessment, product strategy and management, and investor relations. Prior to joining Pacgen, Ms. Rezler served as Director, Investor Relations and Corporate Communications of Arbutus Biopharma Corporation (formerly with Tekmira Pharmaceuticals Corp.), a NASDAQ listed company. She also previously held senior positions with Inflazyme Pharmaceuticals Inc., Metabasis Therapeutics Inc., and Chugai Pharmaceuticals Company Ltd. in Japan. Ms. Rezler received her MA degree and Bachelor of Science degree from the University of Nottingham, United Kingdom. Ms. Rezler has been appointed to the role of Vice President, Corporate Development since October 2015. Ms. Rezler brings to Pacgen over 15 years of international public company experience in the life sciences sector, including countries such as the U.S., Canada, Asia, Europe and Africa. She brings a track record in corporate development and strategy, specializing in customer needs assessment, product strategy and management, and investor relations. Prior to joining Pacgen, Ms. Rezler served as Director, Investor Relations and Corporate Communications of Arbutus Biopharma Corporation (formerly with Tekmira Pharmaceuticals Corp.), a NASDAQ listed company. She also previously held senior positions with Inflazyme Pharmaceuticals Inc., Metabasis Therapeutics Inc., and Chugai Pharmaceuticals Company Ltd. in Japan. Ms. Rezler received her MA degree and Bachelor of Science degree from the University of Nottingham, United Kingdom.

Research Interest

Corporate Development and Strategy Development